Bariatric Surgery Reverses Natural Killer (NK) Cell Activity and NK-Related Cytokine Synthesis Impairment Induced by Morbid Obesity


Autoria(s): MOULIN, Cristiane Martins; MARGUTI, Ivo; PERON, Jean Pierre Schatzmann; HALPERN, Alfredo; RIZZO, Luiz Vicente
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Background Obesity is related to a higher rate of infections and some types of cancer. Here we analyzed the impact of obesity and weight loss induced by Roux-en-Y gastric bypass (RYGB) on immunological parameters, i.e., cytokine productions and natural killer cell function. Methods We analyzed 28 morbidly obese patients before and 6 months after RYGB. Biochemical parameters were analyzed in plasma. The percent of natural killer (NK) cells, their cytotoxicity, and the production of cytokines by peripheral blood mononuclear cells were analyzed. The percent of NK cells was determined by flow cytometry and cytokine production determined by enzyme-linked immunosorbent assay. NK cytotoxicity was determined by the lactate dehydrogenase release assay. Results The weight loss 6 months following surgery was 35.3 +/- 4.5 kg. RYGB also improves biochemical parameters. No significant difference was found in the percent of NK cells after surgery. We found an increase in the production of interferon-gamma, interleukin (IL)-12 and IL-18, but not in IL-2, 6 months after RYGB. Cytotoxic activity of NK cells was significantly enhanced 6 months after RYGB [17.1 +/- 14.7% before RYGB vs 51.8 +/- 11.3% at 6 months after, at 40: 1 effector to target cell ratio; p<0.001]. We observed significant post-surgical improvement in the cytotoxic activity curve in 22 out of 28 patients (78.6%), irrespective of the target to effector cell ratio. Conclusions The weight loss induced by RYGB modifies the production of cytokines related with NK cell function and improves its activity.

Foundation for Aid to Research of the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP)

CAPES

CNPq

CAPES/PNPD[0188085]

Identificador

OBESITY SURGERY, v.21, n.1, p.112-118, 2011

0960-8923

http://producao.usp.br/handle/BDPI/21417

10.1007/s11695-010-0250-8

http://dx.doi.org/10.1007/s11695-010-0250-8

Idioma(s)

eng

Publicador

SPRINGER

Relação

Obesity Surgery

Direitos

closedAccess

Copyright SPRINGER

Palavras-Chave #Morbid obesity #Bariatric surgery #Immunity #Natural killer cells #Weight reduction #GASTRIC BYPASS-SURGERY #IMMUNE FUNCTION #CANCER INCIDENCE #WEIGHT-LOSS #IN-VIVO #LEPTIN #RESPONSES #MICE #MECHANISMS #MORTALITY #Surgery
Tipo

article

original article

publishedVersion